Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-24 @ 8:02 PM
NCT ID:
NCT01968304
Eligibility Criteria:
Inclusion Criteria:
1. Patients aged over 18 years of age.
2. Patients with a locally advanced or metastatic solid cancer (breast, colorectal, prostate, ENT, and lung) scheduled to receive first-line chemotherapy for metastatic disease or Patients with a lymphoma-type hematologic cancer scheduled for first-line chemotherapy
3. Patients who have read the information leaflet and have signed the informed consent.
4. Patients covered by national medical insurance.
Exclusion Criteria:
1. Patients currently undergoing chemotherapy
2. Patients with diagnosed ID
3. Patients having received oral iron or injectable iron treatment during the previous 3 months
4. Patients receiving EPO or transfused during the 3 months prior to inclusion.
5. Patients unable to give their consent.
6. Patients over 18 but under guardianship or public guardianship.
7. Vulnerable individuals as defined by article L1121-5 to -8
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01968304
Study Brief:
Protocol Section:
NCT01968304